RARE DISEASERESEARCH ATLAS

ORPHA:3132

Say-Barber-Miller syndrome

high confidence

Also known as: Microcephaly-hypogammaglobulinemia-abnormal immunity syndrome

Query health: suspect — Only one of 2 strategies returned hits (phrase).

Clinical definition (Orphanet)

A rare multiple anomalies/ syndrome characterized by microcephaly, and , postnatal growth retardation, craniofacial features (including sloping forehead, beaked nose, large and protruding ears, micrognathia, high-arched palate, and craniosynostosis), immunologic abnormalities with transient hypogammaglobulinemia in infancy and defective chemotaxis leading to recurrent infections, as well as autoimmune/autoinflammatory phenomena. Skeletal anomalies and hypogonadism have also been reported.

How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.

Orphanet entry

Is anyone studying this?

2

2 papers have ever been indexed under this name. For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=183) is 38.

2 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 38 (publications denominator n=183).

0 in the last 10 years · high confidence · 2.5th percentile (publications denominator)

Is a treatment being tested?

0

trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).

Data as of 26 July 2026

No matched interventional trials. This is true for 59.2% of diseases in the trials denominator (151 of 255). Here are the researchers publishing on it.

high confidence · 29.6th percentile (trials denominator)

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Who's working on it?

15

Distinct author names in 2 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Ben Hamouda M1 paper · 2009
    Papers in Europe PMC
  2. 02
    Briard ML1 paper · 2001
    Papers in Europe PMC
  3. 03
    Debré M1 paper · 2001
    Papers in Europe PMC
  4. 04
    Edery P1 paper · 2001
    Papers in Europe PMC
  5. 05
    Fischer A1 paper · 2001
    Papers in Europe PMC
  6. 06
    Gouider-Khouja N1 paper · 2009
    Papers in Europe PMC
  7. 07
    Griscelli C1 paper · 2001
    Papers in Europe PMC
  8. 08
    Kechaou I1 paper · 2009

    Service de neurologie pédiatrique, institut national de neurologie, 1007 La Rabta, Tunis, Tunisie.

    Papers in Europe PMC
  9. 09
    Kraoua I1 paper · 2009
    Papers in Europe PMC
  10. 10
    Le Deist F1 paper · 2001
    Papers in Europe PMC

Recruiting interventional trials

Trials testing a treatment from the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

See who's working on it above — people publishing on this disease are often the practical next contact when no trial is listed.

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored below but are not added to the query string.

"Say-Barber-Miller syndrome" OR "Microcephaly-hypogammaglobulinemia-abnormal immunity syndrome"

Run this search on Europe PMC

MeSH descriptor terms unioned into the query: Say Barber Miller syndrome

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Say-Barber-Miller syndrome" OR "Microcephaly-hypogammaglobulinemia-abnormal immunity syndrome" OR "Say Barber Miller syndrome"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Cross-references (from Mondo): MESH:C536618 OMIM:251240 UMLS:C1855078

Query health: suspect — strategies attempted: phrase, mesh; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus

Report an error for ORPHA:3132